Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure

Abstract Aims Transferrin saturation (TSAT), a marker of iron deficiency, reflects both serum concentrations of iron (SIC) and transferrin (STC). TSAT is susceptible to changes in each of these biomarkers. Little is known about determinants of STC and its influence on TSAT and mortality in patients...

Full description

Bibliographic Details
Main Authors: Fraser J. Graham, Pierpaolo Pellicori, Gabriele Masini, Joseph J. Cuthbert, Andrew L. Clark, John G. F. Cleland
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.14438
_version_ 1797661462732210176
author Fraser J. Graham
Pierpaolo Pellicori
Gabriele Masini
Joseph J. Cuthbert
Andrew L. Clark
John G. F. Cleland
author_facet Fraser J. Graham
Pierpaolo Pellicori
Gabriele Masini
Joseph J. Cuthbert
Andrew L. Clark
John G. F. Cleland
author_sort Fraser J. Graham
collection DOAJ
description Abstract Aims Transferrin saturation (TSAT), a marker of iron deficiency, reflects both serum concentrations of iron (SIC) and transferrin (STC). TSAT is susceptible to changes in each of these biomarkers. Little is known about determinants of STC and its influence on TSAT and mortality in patients with heart failure. Accordingly, we studied the relationship of STC to clinical characteristics, to markers of iron deficiency and inflammation and to mortality in chronic heart failure (CHF). Methods and results Prospective cohort of patients with CHF attending a clinic serving a large local population. A total of 4422 patients were included (median age 75 (68–82) years; 40% women; 32% with left ventricular ejection fraction ≤40%). STC ≤ 2.3 g/L (lowest quartile) was associated with older age, lower SIC and haemoglobin and higher high‐sensitivity C‐reactive protein, ferritin and N‐terminal pro‐brain natriuretic peptide compared with those with STC > 2.3 g/L. In the lowest STC quartile, 624 (52%) patients had SIC ≤13 μmol/L, of whom 38% had TSAT ≥20%. For patients in the highest STC quartile, TSAT was <20% when SIC was >13 μmol/L in 185 (17%) patients. STC correlated inversely with ferritin (r = −0.52) and high‐sensitivity C‐reactive protein (r = −0.17) and directly with albumin (r = 0.29); all P < 0.001. In models adjusted for age, N‐terminal pro‐brain natriuretic peptide and haemoglobin, both higher SIC (hazard ratio 0.87 [95% CI: 0.81–0.95]) and STC (hazard ratio 0.82 [95% CI: 0.73–0.91]) were associated with lower mortality. SIC was more strongly associated with both anaemia and mortality than either STC or TSAT. Conclusions Many patients with CHF and a low STC have low SIC even when TSAT is >20% and serum ferritin >100 μg/L; such patients have a high prevalence of anaemia and a poor prognosis and might have iron deficiency but are currently excluded from clinical trials of iron repletion.
first_indexed 2024-03-11T18:45:50Z
format Article
id doaj.art-a02a77272cdb4711ad559a7069d346a3
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-03-11T18:45:50Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-a02a77272cdb4711ad559a7069d346a32023-10-12T02:48:44ZengWileyESC Heart Failure2055-58222023-10-011052826283610.1002/ehf2.14438Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failureFraser J. Graham0Pierpaolo Pellicori1Gabriele Masini2Joseph J. Cuthbert3Andrew L. Clark4John G. F. Cleland5British Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UKBritish Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UKDepartment of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia Brescia ItalyHull University Teaching Hospitals NHS Trust Hull UKHull University Teaching Hospitals NHS Trust Hull UKBritish Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UKAbstract Aims Transferrin saturation (TSAT), a marker of iron deficiency, reflects both serum concentrations of iron (SIC) and transferrin (STC). TSAT is susceptible to changes in each of these biomarkers. Little is known about determinants of STC and its influence on TSAT and mortality in patients with heart failure. Accordingly, we studied the relationship of STC to clinical characteristics, to markers of iron deficiency and inflammation and to mortality in chronic heart failure (CHF). Methods and results Prospective cohort of patients with CHF attending a clinic serving a large local population. A total of 4422 patients were included (median age 75 (68–82) years; 40% women; 32% with left ventricular ejection fraction ≤40%). STC ≤ 2.3 g/L (lowest quartile) was associated with older age, lower SIC and haemoglobin and higher high‐sensitivity C‐reactive protein, ferritin and N‐terminal pro‐brain natriuretic peptide compared with those with STC > 2.3 g/L. In the lowest STC quartile, 624 (52%) patients had SIC ≤13 μmol/L, of whom 38% had TSAT ≥20%. For patients in the highest STC quartile, TSAT was <20% when SIC was >13 μmol/L in 185 (17%) patients. STC correlated inversely with ferritin (r = −0.52) and high‐sensitivity C‐reactive protein (r = −0.17) and directly with albumin (r = 0.29); all P < 0.001. In models adjusted for age, N‐terminal pro‐brain natriuretic peptide and haemoglobin, both higher SIC (hazard ratio 0.87 [95% CI: 0.81–0.95]) and STC (hazard ratio 0.82 [95% CI: 0.73–0.91]) were associated with lower mortality. SIC was more strongly associated with both anaemia and mortality than either STC or TSAT. Conclusions Many patients with CHF and a low STC have low SIC even when TSAT is >20% and serum ferritin >100 μg/L; such patients have a high prevalence of anaemia and a poor prognosis and might have iron deficiency but are currently excluded from clinical trials of iron repletion.https://doi.org/10.1002/ehf2.14438Heart failureIronIron deficiencyMortalityTransferrin saturationTransferrin
spellingShingle Fraser J. Graham
Pierpaolo Pellicori
Gabriele Masini
Joseph J. Cuthbert
Andrew L. Clark
John G. F. Cleland
Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
ESC Heart Failure
Heart failure
Iron
Iron deficiency
Mortality
Transferrin saturation
Transferrin
title Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
title_full Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
title_fullStr Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
title_full_unstemmed Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
title_short Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
title_sort influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure
topic Heart failure
Iron
Iron deficiency
Mortality
Transferrin saturation
Transferrin
url https://doi.org/10.1002/ehf2.14438
work_keys_str_mv AT fraserjgraham influenceofserumtransferrinconcentrationondiagnosticcriteriaforirondeficiencyinchronicheartfailure
AT pierpaolopellicori influenceofserumtransferrinconcentrationondiagnosticcriteriaforirondeficiencyinchronicheartfailure
AT gabrielemasini influenceofserumtransferrinconcentrationondiagnosticcriteriaforirondeficiencyinchronicheartfailure
AT josephjcuthbert influenceofserumtransferrinconcentrationondiagnosticcriteriaforirondeficiencyinchronicheartfailure
AT andrewlclark influenceofserumtransferrinconcentrationondiagnosticcriteriaforirondeficiencyinchronicheartfailure
AT johngfcleland influenceofserumtransferrinconcentrationondiagnosticcriteriaforirondeficiencyinchronicheartfailure